cll-1 cart-t cell
Cell therapyexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2017 (NCT04884984)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- C-type lectin domain family 12 member AImmunity, passive
immunity, passive - cll1
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06307054 | Phase 1 | Mar 15, 2024 | Jiao Tong University |
| NCT05995041 | Phase 1 | Oct 31, 2023 | Shenzhen Geno-Immune Medical Institute |
| NCT05467202 | Phase 1 | Aug 1, 2022 | Zhejiang University |
| NCT04010877 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2019 | Shenzhen Geno-Immune Medical Institute |
| NCT04884984 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2017 | Soochow University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shenzhen Geno-Immune Medical Institute | Academic/Hospital | 2 | 2 | 2 | 2019 |
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Soochow University | Academic/Hospital | 1 | 1 | 1 | 2017 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1